Tarihin en b\u00fcy\u00fck a\u015f\u0131lama kampanyas\u0131 t\u00fcm s\u00fcratiyle devam ediyor. D\u00fcnyada en umut verici dokuz a\u015f\u0131n\u0131n geli\u015fimi merakla takip edilirken, bu vakte kadar d\u00fcnya genelinde toplam yedi a\u015f\u0131, k\u0131s\u0131tl\u0131 \u00f6l\u00e7\u00fclerde kullan\u0131ma sunuldu.<\/p>\n

Bloomberg taraf\u0131ndan toplanan bilgilere nazaran, 42 \u00fclkede 25 milyondan fazla doz a\u015f\u0131 uyguland\u0131. Milyonlarca doz a\u015f\u0131y\u0131 tedarik etmenin ve da\u011f\u0131tman\u0131n, \u015fimdiye kadar \u00fcstlenilen en b\u00fcy\u00fck lojistik zorluklardan biri olaca\u011f\u0131 d\u00fc\u015f\u00fcn\u00fcl\u00fcyor.<\/p>\n

Pfizer-BioNTech firmalar\u0131n\u0131n ortak geli\u015ftirdi\u011fi a\u015f\u0131n\u0131n kullan\u0131m\u0131 \u015fu ana kadar Kuzey Amerika, Avrupa ve Orta Do\u011fu’da onayland\u0131. Datalara nazaran, en az 42 \u00fclkede a\u015f\u0131lama kampanyalar\u0131 ba\u015flat\u0131ld\u0131.<\/p>\n

ABD’deki a\u015f\u0131lama program\u0131 birinci olarak 14 Aral\u0131k’ta s\u0131hhat \u00e7al\u0131\u015fanlar\u0131na uygulanmas\u0131yla ba\u015flad\u0131. \u00dclkede, \u015fu ana kadar 8.02 milyon doz a\u015f\u0131 yap\u0131ld\u0131 ve 272 binin \u00fczerinde ki\u015fi ise iki doz a\u015f\u0131 rejimini tamamlayabildi.<\/p>\n

ABD, 20 milyon dozluk Pfizer-BioNTech ve Moderna a\u015f\u0131s\u0131n\u0131, Ocak ay\u0131n\u0131n ortas\u0131na kadar \u00fclke genelindeki eyaletlere da\u011f\u0131tmay\u0131 ama\u00e7l\u0131yor.<\/p>\n

\u00d6b\u00fcr bir taraftan, AstraZeneca Plc ve Oxford \u00dcniversitesi taraf\u0131ndan geli\u015ftirilen a\u015f\u0131 birinci onay\u0131n\u0131 30 Aral\u0131k’ta \u0130ngiltere taraf\u0131ndan ald\u0131. \u00c7in ayr\u0131yeten, \u015eubat ay\u0131 ba\u015f\u0131nda 50 milyon insan\u0131 a\u015f\u0131lamak emeliyle Sinopharm’\u0131n geli\u015ftirdi\u011fi a\u015f\u0131y\u0131 genel kullan\u0131m i\u00e7in onaylad\u0131.<\/p>\n

\u00c7in, Rusya ve \u0130srail uygulamalarda avantajl\u0131 pozisyonda<\/strong><\/p>\n

Birtak\u0131m \u00fclkeler ise a\u015f\u0131lamada avantajl\u0131 bir ba\u015flang\u0131\u00e7 \u200b\u200byapt\u0131. \u00d6rne\u011fin, \u00c7in ve Rusya test kademeleri tamamlanmadan evvel Temmuz ve A\u011fustos aylar\u0131nda kendi \u00fclkelerinde geli\u015ftirdikleri a\u015f\u0131lara onay verdi. \u00dclkeler, bu m\u00fchlet zarf\u0131nda milyonlarca doz a\u015f\u0131y\u0131 uygulamaya ald\u0131 lakin bu \u00fclkeler a\u015f\u0131lamadaki ilerlemeler hakk\u0131nda daha az s\u0131kl\u0131kta g\u00fcncelleme sa\u011flad\u0131.<\/p>\n

Global a\u015f\u0131lama kampanyas\u0131n\u0131n ba\u015flamas\u0131yla, \u00fclkeler a\u015f\u0131lara e\u015fit olmayan bir eri\u015fim sa\u011flad\u0131. Bir\u00e7ok \u00fclke, \u015fimdi birinci a\u015f\u0131 uygulamas\u0131na ba\u015flamam\u0131\u015fken, \u0130srail\u2019in a\u015f\u0131lama oran\u0131 her 100 bireyde 20.1 doz olarak kaydedildi.<\/p>\n

\u0130lgili Haberler:<\/strong><\/p>\n

\n
• Sinovac\u2019\u0131n Kovid-19 a\u015f\u0131s\u0131na Endonezya\u2019dan onay geldi<\/li>\n
• Global hadise say\u0131s\u0131 90 milyonu a\u015ft\u0131<\/li>\n
• \u0130ngiltere a\u015f\u0131 gayesine ilerliyor<\/li>\n
• Hindistan’da a\u015f\u0131lama tarihi muhakkak oldu<\/li>\n
• Olaylar rekor d\u00fczeylere t\u0131rman\u0131rken, k\u0131s\u0131tlamalar art\u0131r\u0131l\u0131yor<\/li>\n
• AB, Pfizer-Biontech a\u015f\u0131s\u0131 tedarikini ikiye katlad\u0131<\/li>\n
• Bayer koronavir\u00fcs a\u015f\u0131s\u0131 i\u00e7in CureVac ile anla\u015ft\u0131 <\/li>\n<\/ul>\n

  Global a\u015f\u0131lamada yeni tablo<\/strong><\/p>\n

  <\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n

  \n \u00dclke<\/strong><\/p>\n<\/td>\n	\n Toplamda Uygulanan Doz Say\u0131s\u0131<\/strong><\/p>\n<\/td>\n	\n 100 Bireye D\u00fc\u015fen Doz \u00d6l\u00e7\u00fcs\u00fc<\/strong><\/p>\n<\/td>\n	\n En Son G\u00fcncelleme<\/strong><\/p>\n<\/td>\n<\/tr>\n<\/thead>\n
  \n Global Toplam<\/p>\n<\/td>\n	\n 25,839,924<\/em><\/p>\n<\/td>\n	\n \u2013<\/em><\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n \u00c7in<\/p>\n<\/td>\n	\n 9,000,000<\/p>\n<\/td>\n	\n 0.64<\/p>\n<\/td>\n	\n 08 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n ABD<\/p>\n<\/td>\n	\n 8,017,552<\/p>\n<\/td>\n	\n 2.44<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n \u0130ngiltere<\/p>\n<\/td>\n	\n 2,000,000<\/p>\n<\/td>\n	\n 2.99<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n \u0130srail<\/p>\n<\/td>\n	\n 1,817,000<\/p>\n<\/td>\n	\n 20.08<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n B.A.E<\/p>\n<\/td>\n	\n 1,086,568<\/p>\n<\/td>\n	\n 10.11<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Rusya<\/p>\n<\/td>\n	\n 800,000<\/p>\n<\/td>\n	\n 0.55<\/p>\n<\/td>\n	\n 02 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n \u0130talya<\/p>\n<\/td>\n	\n 627,946<\/p>\n<\/td>\n	\n 1.04<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Almanya<\/p>\n<\/td>\n	\n 532,878<\/p>\n<\/td>\n	\n 0.64<\/p>\n<\/td>\n	\n 09 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Kanada<\/p>\n<\/td>\n	\n 314,492<\/p>\n<\/td>\n	\n 0.84<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n \u0130spanya<\/p>\n<\/td>\n	\n 277,976<\/p>\n<\/td>\n	\n 0.60<\/p>\n<\/td>\n	\n 08 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Polonya<\/p>\n<\/td>\n	\n 200,022<\/p>\n<\/td>\n	\n 0.53<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Suudi Arabistan<\/p>\n<\/td>\n	\n 130,000<\/p>\n<\/td>\n	\n 0.38<\/p>\n<\/td>\n	\n 07 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Danimarka<\/p>\n<\/td>\n	\n 114,926<\/p>\n<\/td>\n	\n 1.98<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Romanya<\/p>\n<\/td>\n	\n 108,294<\/p>\n<\/td>\n	\n 0.56<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Arjantin<\/p>\n<\/td>\n	\n 107,542<\/p>\n<\/td>\n	\n 0.24<\/p>\n<\/td>\n	\n 08 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Fransa<\/p>\n<\/td>\n	\n 93,000<\/p>\n<\/td>\n	\n 0.14<\/p>\n<\/td>\n	\n 09 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Bahreyn<\/p>\n<\/td>\n	\n 89,250<\/p>\n<\/td>\n	\n 6.01<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Portekiz<\/p>\n<\/td>\n	\n 70,000<\/p>\n<\/td>\n	\n 0.68<\/p>\n<\/td>\n	\n 08 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Meksika<\/p>\n<\/td>\n	\n 67,468<\/p>\n<\/td>\n	\n 0.05<\/p>\n<\/td>\n	\n 08 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Yunanistan<\/p>\n<\/td>\n	\n 44,080<\/p>\n<\/td>\n	\n 0.41<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Macaristan<\/p>\n<\/td>\n	\n 42,549<\/p>\n<\/td>\n	\n 0.44<\/p>\n<\/td>\n	\n 08 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n \u0130sve\u00e7<\/p>\n<\/td>\n	\n 40,000<\/p>\n<\/td>\n	\n 0.39<\/p>\n<\/td>\n	\n 07 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Hollanda<\/p>\n<\/td>\n	\n 31,000<\/p>\n<\/td>\n	\n 0.18<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Slovakya<\/p>\n<\/td>\n	\n 26,251<\/p>\n<\/td>\n	\n 0.48<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n H\u0131rvatistan<\/p>\n<\/td>\n	\n 24,985<\/p>\n<\/td>\n	\n 0.61<\/p>\n<\/td>\n	\n 08 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Litvanya<\/p>\n<\/td>\n	\n 22,191<\/p>\n<\/td>\n	\n 0.80<\/p>\n<\/td>\n	\n 09 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Slovenya<\/p>\n<\/td>\n	\n 19,930<\/p>\n<\/td>\n	\n 0.96<\/p>\n<\/td>\n	\n 09 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n \u00c7ek Cumhuriyeti<\/p>\n<\/td>\n	\n 19,918<\/p>\n<\/td>\n	\n 0.19<\/p>\n<\/td>\n	\n 07 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Norve\u00e7<\/p>\n<\/td>\n	\n 17,337<\/p>\n<\/td>\n	\n 0.32<\/p>\n<\/td>\n	\n 08 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Avusturya<\/p>\n<\/td>\n	\n 15,905<\/p>\n<\/td>\n	\n 0.18<\/p>\n<\/td>\n	\n 07 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n \u0130rlanda<\/p>\n<\/td>\n	\n 15,314<\/p>\n<\/td>\n	\n 0.31<\/p>\n<\/td>\n	\n 07 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Umman<\/p>\n<\/td>\n	\n 15,023<\/p>\n<\/td>\n	\n 0.36<\/p>\n<\/td>\n	\n 10 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Bulgaristan<\/p>\n<\/td>\n	\n 13,473<\/p>\n<\/td>\n	\n 0.19<\/p>\n<\/td>\n	\n 09 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Finlandiya<\/p>\n<\/td>\n	\n 11,135<\/p>\n<\/td>\n	\n 0.20<\/p>\n<\/td>\n	\n 08 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Estonya<\/p>\n<\/td>\n	\n 10,197<\/p>\n<\/td>\n	\n 0.77<\/p>\n<\/td>\n	\n 09 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n \u0130zlanda<\/p>\n<\/td>\n	\n 4,917<\/p>\n<\/td>\n	\n 1.38<\/p>\n<\/td>\n	\n 05 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Letonya<\/p>\n<\/td>\n	\n 4,595<\/p>\n<\/td>\n	\n 0.24<\/p>\n<\/td>\n	\n 07 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Kuveyt<\/p>\n<\/td>\n	\n 2,500<\/p>\n<\/td>\n	\n 0.05<\/p>\n<\/td>\n	\n 29 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n Kosta Rika<\/p>\n<\/td>\n	\n 2,455<\/p>\n<\/td>\n	\n 0.05<\/p>\n<\/td>\n	\n 03 Ocak<\/p>\n<\/td>\n<\/tr>\n
  \n L\u00fcksemburg<\/p>\n<\/td>\n	\n 1,200<\/p>\n<\/td>\n	\n 0.20<\/p>\n<\/td>\n	\n 30 Aral\u0131k<\/p>\n<\/td>\n<\/tr>\n
  \n Gine<\/p>\n<\/td>\n	\n 55<\/p>\n<\/td>\n	\n 0.00<\/p>\n<\/td>\n	\n 30 Aral\u0131k<\/p>\n<\/td>\n<\/tr>\n
  \n \u015eili<\/p>\n<\/td>\n	\n \u2013<\/p>\n<\/td>\n	\n \u2013<\/p>\n<\/td>\n	\n 09 Ocak<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Bloomberg HT<\/span><\/p>\n","protected":false},"excerpt":{"rendered":" Tarihin en b\u00fcy\u00fck a\u015f\u0131lama kampanyas\u0131 t\u00fcm s\u00fcratiyle devam ediyor. D\u00fcnyada en umut verici dokuz a\u015f\u0131n\u0131n geli\u015fimi merakla takip edilirken, bu vakte …<\/p>\n","protected":false},"author":1,"featured_media":20094,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[196,2119,2052,1905,127],"class_list":["post-20093","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ekonomi","tag-asi","tag-asilama","tag-ocak","tag-onay","tag-ulke"],"yoast_head":"\n